This year, funding fell from $10.5 billion in the first quarter down to the lowest funding has been at $4.6 billion today, according to a report from HealthcareDive.
Funding for digital health is decreasing back to its lowest levels since 2019. Market adjustments and inflation and interest rates may be to thank.
COVID-19 brought telehealth its biggest break in 2020 when healthcare and much of the world operated and delivered care virtually. At an average of $5.4 billion in funding in 2019, telehealth's worth skyrocketed to its highest of $16.8 billion 2021, being one of the biggest demands in healthcare.
This year, funding fell from $10.5 billion in the first quarter down to the lowest funding has been at $4.6 billion today, according to a report from HealthcareDive.
The decrease in funding is severe for clinical trials tech, telehealth and health IT, though telehealth and health IT continue to see some of the highest funding amounts overall.
According to the report, CB Insights said this year's total telehealth funding is projected to be less than half of what the sector brought in during 2021.
2023 Drug Trend Report - Xevant
May 16th 2024To effectively navigate the changing pharmacy landscape and maintain a robust, cost-effective pharmacy benefit, you must understand the forces behind rising drug trend. What’s driving your costs and what can you do about it? As a leader in the PBM analytics space, we offer a unique perspective on pivotal trend drivers. Here’s what our comprehensive analysis revealed: -A surge in utilization rates across specialty and non-specialty drugs, magnified by anti-obesity therapies -Financial strain imposed by anti-inflammatory biologics and the yet-to-be-fulfilled -promise of biosimilar savings -Persistent price inflation driving higher costs year over year
Read More